In summary, a GO nanomaterial-functionalized microfluidic fluorescence biosensor fabricated by a simple process is proposed for the simultaneous detection of CA125, HE4, APF and CEA in serum for ovarian tumor/cancer screening and diagnosis. The gene discussed is CEACAM5; the disease is ovarian neoplasm.